title: Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases.
abstract: The emergence and re-emergence of bacterial strains that are resistant to current antibiotics reveal the clinical need for new agents that possess broad-spectrum antibacterial activity. Furthermore, bacteriophobic coatings that repel bacteria are important for medical devices, as the lifetime, reliability, and performance of implant devices are hindered by bacterial adhesion and infection. Dendrimers, a specific class of monodisperse macromolecules, have recently shown potential to function as both antibacterial agents and antimicrobial surface coatings. This review discusses the limitations with currently used antibacterial agents and describes how various classes of dendrimers, including glycodendrimers, cationic dendrimers, anionic dendrimers, and peptide dendrimers, have the potential to improve upon or replace certain antibiotics. Furthermore, the unexplored areas in this field of research will be mentioned to present opportunities for additional studies regarding the use of dendrimers as antimicrobial agents.
authors: Department of Biomedical Engineering and Chemistry, Boston University, Boston, Massachusetts 02215, United States.
authors: Meredith A
authors: MA
authors: Mintzer
authors: Eric L
authors: EL
authors: Dane
authors: George A
authors: GA
authors: O'Toole
authors: Mark W
authors: MW
authors: Grinstaff
mesh_terms: D021821:Communicable Diseases, Emerging / Q000188:drug therapy*; D050091:Dendrimers / Q000737:chemistry*; D004337:Drug Carriers / Q000737:chemistry*; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans
chemical_list: D050091:Dendrimers; D004337:Drug Carriers